Report
Dave Nicoski ...
  • Ross LaDuke
EUR 43.33 For Business Accounts Only

Vital Signs: Actionable charts

n this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
Underlyings
10x Genomics Inc Class A

Adaptive Biotechnologies

Adaptive is advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. The company offers testing instruments for diagnose, treat, and monitor disease. The company serves customers in the United States.

ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical and immunoglobulin company that manufactures, markets and develops plasma-derived biologics for the treatment of immune deficiencies and the prevention and treatment of certain infectious diseases. The company's marketed products consist of: Nabi-HB, which is indicated for the treatment of acute exposure to blood containing Hepatitis B surface antigen; and Bivigam, which is indicated for the treatment of primary humoral immunodeficiency. The company is also developing a pipeline of plasma-derived therapeutics, including its key pipeline product candidate, RI-002, for the treatment of Primary Immune Deficiency Disease.

Arcus Biosciences

Arcus Biosciences is a clinical-stage biopharmaceutical company focused on creating cancer immunotherapies. The company has four clinical-stage product candidates: AB928, which is an orally bioavailable, reversible antagonist of the adenosine 2a and adenosine 2b receptors; AB680, which is a reversible and selective inhibitor of the CD73 enzyme; AB122, which is a human antibody with similar binding affinity and other characteristics to the marketed anti-PD-1 antibodies pembrolizumab and nivolumab; and AB154, which is a humanized antibody that inhibits an immune checkpoint target involved in a pathway that plays both inhibitory and stimulatory roles in the immune system.

BETA BIONICS

Biogen Inc.

Biogen is a biopharmaceutical company focused on discovering, developing and delivering therapies for people living with neurological and neurodegenerative diseases as well as related therapeutic adjacencies. The company's main growth areas include multiple sclerosis (MS) and neuroimmunology; Alzheimer's disease and dementia; neuromuscular disorders, including spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis; movement disorders, including Parkinson's disease; and ophthalmology. The company's marketed products include TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, VUMERITY and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA and FUMADERM for the treatment of severe plaque psoriasis.

Castle Biosciences

Castle Biosciences is a commercial-stage dermatological cancer company focused on providing physicians and their patients with personalized, clinically actionable genomic information to make treatment decisions. The company's main product, DecisionDx-Melanoma, is a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis or recurrence for patients diagnosed with invasive cutaneous melanoma, a deadly skin cancer. The company also markets DecisionDx-UM, which is a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma, a rare eye cancer. The company is developing additional products in treating their patients' skin cancer, such as DecisionDx-SCC.

CCH HOLDINGS LTD

Computer Programs & Systems Inc.

Computer Programs and Systems provides healthcare solutions and services. The company provides its products and services through Evident, LLC (Evident), TruBridge, LLC (TruBridge), and American HealthTech, Inc. (AHT). Evident provides acute care electronic health record (EHR) solution, Thrive, and related services for community hospitals and their physician clinics. TruBridge focuses on providing business management, consulting, and managed IT services, along with its revenue cycle management solution for all care settings, regardless of their healthcare information solutions provider. AHT provides post-acute care EHR solution and related services for skilled nursing and assisted living facilities.

FORTE BIOSCIENCES INC

G. Willi-Food International Ltd.

G. Willi-Food International is engaged, directly and through subsidiaries, in the development, import, export, marketing and distribution of a variety of over 600 food products world-wide. Co. sells products in Israel with widespread demand in the Israeli marketplace, as well as products which cater to more select groups. Co. purchases food products from approximately 150 suppliers located in Israel and throughout the world. Co.'s products are marketed and sold to over 1,500 customers in Israel and around the world. Co. imports, manufactures, markets and distributes through its import segment.

GREENFIRE RESOURCES LTD

Hartford Financial Services Group Inc.

Hartford Financial Services Group is a holding company. Through its subsidiaries, the company provides property and casualty insurance, group benefits insurance and services, and mutual funds and exchange-traded products. The company has five segments: Commercial Lines, which provides automobile, property, general liability, and marine coverages; Personal Lines, which provides automobile and homeowners coverages; Property and Casualty Other Operations, which provides group life, group disability, and other products; and Hartford Funds, which provides mutual fund, exchange-traded products, and Talcott Resolution life and annuity separate accounts.

Herbalife Nutrition Ltd.

Herbalife Nutrition is a holding company. Through its subsidiaries, the company is a nutrition company. The company's products categories are: weight management, which provides meal replacement, protein shakes, drink mixes, weight loss solutions and healthy snacks; targeted nutrition, which provides beverages and dietary and nutritional supplements containing herbs, vitamins, minerals and other natural ingredients; energy, sports, and fitness, which provides products that support a healthy active lifestyle; outer nutrition, which provides facial skin care, body care, and hair care; and literature, promotional and other, which provides start-up kits, sales tools, and educational materials.

Hooker Furniture Corp.

Hooker Furniture is a designer, marketer and importer of casegoods (wooden and metal furniture), leather furniture and fabric-upholstered furniture. The company is organized into two segments: Hooker Branded, which includes Hooker Casegoods that covers a range of design categories and includes home entertainment, home office, accent, dining and bedroom furniture in the upper-medium price points sold under the Hooker Furniture brand; and Home Meridian, which includes Accentrics Home, home furnishings centered around a mix of pieces and materials that provide a take on home fashion, and Samuel Lawrence Furniture, focuses on offerings in bedroom, dining room, home office and youth furnishings.

Intuitive Surgical Inc.

Intuitive Surgical develops, manufactures, and markets the da Vinci? Surgical System and the Ion? endoluminal system. The systems consist of a surgeon console or consoles, a patient-side cart, a vision system, and proprietary instruments and accessories. The company's technology is designed to provide surgeons with a range of motion analogous to the motions of a human wrist, while filtering out the tremors inherent in a surgeon's hands. The company's primary platform for robotic-assisted surgery is its family of da Vinci Surgical Systems. The da Vinci Surgical System allows surgeons to operate while seated at an ergonomic console viewing a three-dimensional image of the surgical field.

KALARIS THERAPEUTICS INC

LaZBoy Incorporated

La-Z-Boy manufactures, markets, imports, exports, distributes and retails upholstery furniture products. In addition, the company imports, distributes and retails accessories and casegoods (wood) furniture products. The company's reportable operating segments are: Upholstery, which manufactures and imports upholstered furniture such as recliners and motion furniture, sofas, loveseats, chairs, sectionals, modulars, ottomans and sleeper sofas; Casegoods, which imports, markets, and distributes casegoods (wood) furniture as well as manufactures some custom upholstered furniture; and Retail, which sells upholstered furniture, in addition to some casegoods and other accessories.

MAXIMUS Inc.

MAXIMUS is an operator of government health and human services programs worldwide. The company's segments are: United States Health and Human Services, which provides a variety of business process services such as program administration, appeals and assessments work and related consulting work; United States Federal Services, which provides program administration, appeals and assessments services and technology solutions, including system and software development and maintenance services; and Outside the United States, which provides business process services solutions for governments and commercial clients in geographies beyond the United States, including health and disability assessments.

Natera

Natera is a diagnostics company. The company engages in the discovery, development and commercialization of genetic testing services. The company's product offerings include: Panorama Non-Invasive Prenatal Test, which screens for chromosomal abnormalities of a fetus typically with a blood draw from the mother; Vistara, a single-gene mutations screening test performed to identify single-gene disorders; Horizon Carrier Screening, which determines carrier status for a number of severe genetic diseases that could be passed on to the carrier's children; and Spectrum, which analyzes chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle to select embryos for a pregnancy.

Nurix Therapeutics

NUTEX HEALTH INC

PACS GROUP INC

SOLVENTUM CORPORATION

Steven Madden Ltd.

Steven Madden designs, sources, markets and sells name brand and private label footwear for women, men and children and name brand and private label handbags and accessories. The company licenses its trademarks for use in connection with the manufacturing, marketing and sale of various products by third party licensees. The company's products are marketed through its retail stores and its e-commerce websites within the U.S., Canada, Mexico, the company's joint ventures in South Africa, China, Taiwan and Israel, as well as department stores, specialty stores, retailers, national chains, mass merchants, online retailers and catalog retailers throughout the U.S., Canada, Mexico, certain European nations and Tunisia.

Tandem Diabetes Care

Tandem Diabetes Care is a medical device company engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The company primarily focuses on the t:slim X2 Insulin Delivery System, or t:slim X2, the company's key pump platform that is capable of remote feature updates and designed to display continuous glucose monitoring sensor information directly on the pump home screen. In addition to selling insulin pumps, the company sells disposable products that are used together with the pumps and are replaced every few days, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to a user's body.

TYRA BIOSCIENCES INC

Veracyte Inc

Veracyte is a genomic diagnostics company. The company's products include the following: Afirma Genomic Sequencing Classifier and Xpression Atlas, which includes the Afirma GSC and Xpression Atlas; Percepta Bronchial Genomic Classifier, which improves lung cancer diagnosis by improving the performance of diagnostic bronchoscopies; Envisia Genomic Classifier, which improves diagnosis of idiopathic pulmonary fibrosis; and Prosigna Breast Cancer Prognostic Gene Signature Assay, which uses genomic technology to inform next steps for patients with early-stage breast cancer, based on the genomic make-up of their disease.

Provider
Vermilion Research
Vermilion Research

Vermilion Research delivers timely, actionable, and unique research inputs to professional investors. Our research strategists highlight securities which we believe are at major inflection points, based on our various proprietary technical indicators, and offer asymmetric risk/return profiles. We believe our research methodology, which is not limited by industry sector or market capitalization, enables us to deliver superior investment recommendations.

Our process begins by organizing all actively traded stocks into coherent sectors, then into logical industry groups. We then apply our proprietary relative strength tools to identify developing price trends. Once attractive trends are identified within a selected sectors or groups, we screen for individual stocks which we believe offer the best risk/reward profile. Vermilion offers U.S. and global equity market research products. Vermilion’s research team, which has received numerous awards and accolades, has a combined 70 year of experience in the analysis of investment securities.

Analysts
Dave Nicoski

Ross LaDuke

Other Reports on these Companies
Other Reports from Vermilion Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch